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ABSTRACT
Approximately, 1 in 8 women in the US will develop invasive breast
cancer and 1 in 33 will die. Breast Cancer is a major health disparity for
women all over the globe, having the largest impact on African
Americanwomen under the age of 45. Despite medical advances, the
5-year survivorshipamong breast cancer patients remains significantly
low largelydue to high recurrence rates and propensity for metastasis
to distal organs. (e.g., lung, liver,brain). Thus, further knowledge of the
mechanisms which promote tumor development and progression is
needed to advance cancer treatment. Tumor cells are known to secrete
and express immune modulators as a mechanism to invade host
antitumor immune responses. Using an experimentalmurine tumor cell
line, our preliminaryresults demonstrate the expression of interleukin-4
receptor (IL-4R). We hypothesize that IL-4R activity plays a role in
mediation of tumor cell function. In this study, 4T1 mammary
adenocarcinoma cells were exposed to IL-4R ligands, interleukin-4 (IL-
4), interleukin-13 (IL-13) and their ability to influence TNF-α, TGF-β1
and CCL4 expression by 4T1 cells. Our results demonstrated an
increase growth and CCL4 mRNA expression in response to IL-4 in
combination with IL-13, suggesting a potential target to mitigate tumor
progression.
● Cell Cultures: 4T1 cells were seeded in T-75 culture flasks and
incubated at 37ºC at 5% CO2 until reaching70% confluency.
● 6 Well Cultures: 4T1 cells were seeded in 6 well culture plates and
stimulated with 20 ng/mL of IL-4, IL-13, or a combination of IL-4, IL-
13. or culture media as a control.
● Microscopic Visualization: Light field images were taken on 2
consecutive days. Each image represents the centermost aspect of
the 6 well plate in triplicate at 10X magnification.
● Total RNA Extraction: Total RNA from 4T1 cells were extracted
using RNA easy column separationtechniques (Invitrogen).
● Quantitative RT-PCR : cDNA was generated using a starting Total
RNA concentration of 1 μg per reaction and MLV (Molony murine
leukemia virus) reverse transcriptase (Promega Corp., Madison, WI,
USA). After cDNA synthesis, real-time PCR was performed using
SYBR green-based amplification techniques. PCR was performed in
a 20 μl reaction volume using the StepOne system (Applied
Biosystems Inc., Foster City, CA, USA).
● Quantitation of mRNA gene expression: TNF-α, TGF-β 1 and CCL-4
was quantified using




Breast cancer is the second most common cancer among women in
the United States. A major obstacle in the treatment of invasive breast
cancer is its propensity to metastasize to distal organs, resulting in
poor survivorship. Mechanisms which promote tumor progression
include the ability of the tumor microenvironment to escape immune
defenses (2,4). Specifically, the tumor microenvironment is capable of
secreting immunosuppressive cytokines and chemokines which
promote growth and spread of tumor cells (2,4,6). Both IL-4 and IL-13
cytokines are anti-inflammatory cytokines that regulate
immunomodulatory responses by suppressing pro-inflammatory
cellular signals. Previous studies have show that tumor cells can
express IL-4 and their cognate IL-4 (IL-4R). Receptor as well as
chemotactic factors that can recruit immunosuppressive cells and
promoting tumor growth (1,4,5). To gain further insight of the role of IL-
4 and IL-13 on tumor cell-mediated immune suppression, studies were
conducted to assess the effects of IL-4 and IL-13 on tumor cell
growth, cytokine and chemokine expression. Using the murine breast
cancer cell line, 4T1 mammary adenocarcinoma, we demonstrate the
synergistic effect of IL-4 and IL-13 on tumor growth and CCL4
chemokine mRNA expression. Our findings support our working
hypothesis that IL-4R signaling increases cytokine and chemokine
factors by tumor cells which promote the downstream recruitment and




The tumor cell microenvironment is highly immunosuppressive.
Chemokines and cytokines expressed by the tumor microenvironment
can promote immune suppression. Here we propose that increased
CCL4 production and ligation to CCR5 expressing T regulatory cells
promote the development and progression of the tumor
microenvironment (Figure. 1.)
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Figure1. Role of CCL4 in promoting immune evasion by tumor cells
• IL-4 plus IL-13 enhances the growth of murine 4T1 adenocarcinoma. 
Mammary tumor cells
• TNF-α, TGF-β and CCL4 mRNA gene expression. By 4T1 
adenocarcinoma. Mammary tumor cells was not significantly altered 
by IL-4 or IL-13 alone.
• IL-4 plus IL-13 significantly increased CCL4 mRNA gene expression 
by 4T1 adenocarcinoma. Mammary tumor cells
